The Board of Directors proposes a dividend of 0.35 CHF per registered share
Harry Kirsch proposed as new independent member of the Board of Directors
Delphine Viguier-Hovasse and Samuel du Retail proposed as two non-independent board members from L’Oréal
ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today published the invitation and agenda for its 2026 Annual General Meeting (AGM), which will be held virtually on April 22, 2026, at 3:00pm CEST.
Dividend proposal
The Board of Directors proposes a dividend of 0.35 CHF per registered share of Galderma following its record 2025 performance. If approved by shareholders, the dividend will be paid out of reserves from capital contributions and, in accordance with applicable tax regulations, will be free from Swiss withholding tax.
Proposed elections to the Board of Directors of Galderma Group AG
As previously announced, and in connection with L’Oréal’s increased investment in Galderma, the Board members representing the consortium led by EQT, Michael Bauer and Marcus Brennecke, will not stand for re-election and will step down from the Board at the conclusion of the 2026 AGM. Delphine Viguier-Hovasse, Chief Innovation & Prospective Officer at L’Oréal, and Samuel du Retail, Managing Director of Artificial Intelligence, Data and Shared Services at L’Oréal, will be proposed by L’Oréal to shareholders for election as non-independent members.
The Board of Directors will also propose the appointment of Harry Kirsch, former Chief Financial Officer of Novartis, as a new independent member, as well as the re-election of the following current members, each for a one-year term until the completion of the next AGM:
- Thomas Ebeling (Chair)
- Daniel Browne
- Maria Teresa Hilado
- Karen Lee Ling
- Roberto Marques
- Sherilyn McCoy
- Flemming Ørnskov, M.D., MPH
|
THOMAS EBELING CHAIR OF THE BOARD OF DIRECTORS
GALDERMA |
|
